# Education and Awareness Program Targeting the Assessment of Adherence of the Treatment of Dyslipidemia

> **NCT00557778** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 600 (actual)

## Conditions studied

- Patients With Dyslipidemia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00557778
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 600 (ACTUAL)
- **Last updated:** 2011-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00557778

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00557778, "Education and Awareness Program Targeting the Assessment of Adherence of the Treatment of Dyslipidemia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00557778. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*